Why the French "passe sanitaire" did nothing to solve COVID vaccine inequalities

In a recent study published on the medRxiv* preprint server, researchers determined factors influencing local heterogeneities in coronavirus disease 2019 (COVID-19) vaccination rates and the influence of the French sanitary pass on those heterogeneities using extensive nationwide data from France.

Study: The French domestic "sanitary pass" did not solve Covid-19 vaccination inequities in France. Image Credit: rarrarorro / Shutterstock.com

Study: The French domestic "sanitary pass" did not solve Covid-19 vaccination inequities in France. Image Credit: rarrarorro / Shutterstock.com

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Background

Although France has a demonstrated history of unwillingness towards vaccination that was confirmed during the COVID-19 pandemic, the acceptance of COVID-19 vaccination in France gradually rose throughout 2021.

Social and territorial inequalities are known to influence people's attitudes towards vaccination. For example, according to surveys conducted in 2020, vaccination rates in France are influenced by interviewees' level of education, income, and confidence in authorities.

To improve COVID-19 vaccination rates, France President Macron announced the implementation of a domestic sanitary pass (le passe sanitaire) on July 12, 2021, which was entirely implemented by August 9, 2021. The health pass was required in most public venues, such as outdoor and indoor dining areas and medical establishments. However, to date, the detailed information on the impact of the French sanitary pass on vaccination inequalities has not been fully assessed.

About the study

In the present study, the association between socioeconomic and geographic factors, COVID-19 vaccination, and health pass implementation in France was determined using comprehensive nationwide data.

The vaccination, socioeconomic, and geographic indicators data were collected from the French State Health Insurance Service (Assurance Maladie) public datasets. The Assurance Maladie provides public datasets of in-depth weekly COVID-19 first-dose vaccination data at the district scale across the country and at the suburban scale for the Marseille, Paris, and Lyon metropolitan areas.

The study included data of 63,601,670 individuals from 1,552 mainland French districts. These districts were associated with the five geographic and 176 socioeconomic indicators obtained from the same public datasets.

The relationship between being a district in the lowest quartile of first-dose vaccination rate and above the median value of each indicator was determined. Subsequently, the socioeconomic and geographic indicators odds ratio (OR) and their 95% confidence interval (CI) were determined on three timestamps that accounted for the before and after effects of health pass implementation.

The vaccination rates for the two socioeconomic and geographic indicators with the highest OR on the same dates were calculated. The analyses were conducted using R (v4.0.3) software.

Study findings

Both the income rate from unemployment benefits and the proportion of overcrowded households were found to be the most associated with local vaccination rates. To this end, the OR of unemployment and overcrowding at weeks 27, 31, and 37 were 12.6, 13.3, 11.9, and 11.6, 12, 15.7, with a 95% CI of [8.7; 18.9], [9.1; 20.0], and [8.2; 17.6], respectively.

The differences in percentile points-based vaccination rates between the first and fourth quartiles of unemployment and overcrowding indicators remained similar across the weeks. At weeks 27, 31, and 35, the difference in vaccination rate of unemployment was 7.6, 8, and 7.9 with a 95% CI of [6.6; 8.7], [7.0; 9.0], and [6.9; 8.9], respectively. The difference in vaccination rate of overcrowding at weeks 27, 31, and 35 were 6.9, 7.6, and 8.2 with a 95% CI of [5.7; 8.1], [6.6; 8.8], and [7.2; 9.1], respectively.

Local vaccination rates depending on the quartile of the two main indicators (Overcrowding rate, left and Unemployment rate, right) and over time (weeks 27, 31, 35, with increasingly darker shading)

Conclusions

The study results demonstrate that many deprived areas in France had more than ten times the likelihood of being among districts with the lowest vaccination rates. Low vaccination rates in France were associated with economically poor populations, thus indicating that the health pass did not resolve vaccination inequalities.

Districts with a large fraction of overcrowded housing or unemployment benefits constituting a large share of local income were strong determinants for low vaccination rates.

Previous studies have shown that most deprived areas had disproportional COVID-19 infection and hospitalization rates throughout the pandemic. The present study provides robust evidence for the strong impact of social inequalities on COVID-19 management.

Economically backward districts were the least vaccinated and at risk, despite implementing the domestic sanitary pass. Taken together, the current study underscores the pressing need for establishing new vaccination guidelines that address social inequalities.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Journal references:

Article Revisions

  • May 10 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.
Shanet Susan Alex

Written by

Shanet Susan Alex

Shanet Susan Alex, a medical writer, based in Kerala, India, is a Doctor of Pharmacy graduate from Kerala University of Health Sciences. Her academic background is in clinical pharmacy and research, and she is passionate about medical writing. Shanet has published papers in the International Journal of Medical Science and Current Research (IJMSCR), the International Journal of Pharmacy (IJP), and the International Journal of Medical Science and Applied Research (IJMSAR). Apart from work, she enjoys listening to music and watching movies.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Susan Alex, Shanet. (2023, May 10). Why the French "passe sanitaire" did nothing to solve COVID vaccine inequalities. News-Medical. Retrieved on November 17, 2024 from https://www.news-medical.net/news/20220110/Why-the-French-passe-sanitaire-did-nothing-to-solve-COVID-vaccine-inequalities.aspx.

  • MLA

    Susan Alex, Shanet. "Why the French "passe sanitaire" did nothing to solve COVID vaccine inequalities". News-Medical. 17 November 2024. <https://www.news-medical.net/news/20220110/Why-the-French-passe-sanitaire-did-nothing-to-solve-COVID-vaccine-inequalities.aspx>.

  • Chicago

    Susan Alex, Shanet. "Why the French "passe sanitaire" did nothing to solve COVID vaccine inequalities". News-Medical. https://www.news-medical.net/news/20220110/Why-the-French-passe-sanitaire-did-nothing-to-solve-COVID-vaccine-inequalities.aspx. (accessed November 17, 2024).

  • Harvard

    Susan Alex, Shanet. 2023. Why the French "passe sanitaire" did nothing to solve COVID vaccine inequalities. News-Medical, viewed 17 November 2024, https://www.news-medical.net/news/20220110/Why-the-French-passe-sanitaire-did-nothing-to-solve-COVID-vaccine-inequalities.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study reveals how COVID-19 affected the spread and evolution of seasonal influenza